Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HIY9
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 13 |
GO:0016043 | cellular component organization | 3 | 13 |
GO:0022607 | cellular component assembly | 4 | 13 |
GO:0043933 | protein-containing complex organization | 4 | 13 |
GO:0065003 | protein-containing complex assembly | 5 | 13 |
GO:0070286 | axonemal dynein complex assembly | 6 | 13 |
GO:0071840 | cellular component organization or biogenesis | 2 | 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 13 |
GO:0005515 | protein binding | 2 | 13 |
GO:0051087 | protein-folding chaperone binding | 3 | 13 |
GO:0045505 | dynein intermediate chain binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 13 | 17 | PF00656 | 0.618 |
CLV_C14_Caspase3-7 | 244 | 248 | PF00656 | 0.538 |
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.613 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.413 |
CLV_PCSK_PC1ET2_1 | 22 | 24 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.581 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.527 |
CLV_PCSK_SKI1_1 | 254 | 258 | PF00082 | 0.340 |
CLV_Separin_Metazoa | 204 | 208 | PF03568 | 0.474 |
DEG_APCC_DBOX_1 | 201 | 209 | PF00400 | 0.558 |
DOC_CYCLIN_RxL_1 | 251 | 258 | PF00134 | 0.372 |
DOC_CYCLIN_yCln2_LP_2 | 95 | 101 | PF00134 | 0.665 |
DOC_MAPK_gen_1 | 254 | 261 | PF00069 | 0.505 |
DOC_MAPK_MEF2A_6 | 254 | 261 | PF00069 | 0.481 |
DOC_PP2B_LxvP_1 | 233 | 236 | PF13499 | 0.474 |
DOC_PP2B_LxvP_1 | 78 | 81 | PF13499 | 0.522 |
DOC_PP4_FxxP_1 | 163 | 166 | PF00568 | 0.424 |
DOC_PP4_FxxP_1 | 21 | 24 | PF00568 | 0.501 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.565 |
DOC_USP7_MATH_1 | 41 | 45 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.720 |
LIG_14-3-3_CanoR_1 | 148 | 153 | PF00244 | 0.572 |
LIG_14-3-3_CanoR_1 | 207 | 212 | PF00244 | 0.528 |
LIG_14-3-3_CanoR_1 | 224 | 228 | PF00244 | 0.361 |
LIG_Actin_WH2_2 | 211 | 226 | PF00022 | 0.485 |
LIG_BRCT_BRCA1_1 | 38 | 42 | PF00533 | 0.633 |
LIG_FHA_1 | 198 | 204 | PF00498 | 0.508 |
LIG_FHA_1 | 256 | 262 | PF00498 | 0.492 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.480 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.423 |
LIG_FHA_2 | 242 | 248 | PF00498 | 0.538 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.571 |
LIG_LIR_Apic_2 | 162 | 166 | PF02991 | 0.506 |
LIG_LIR_Apic_2 | 20 | 24 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 179 | 185 | PF02991 | 0.461 |
LIG_PCNA_PIPBox_1 | 109 | 118 | PF02747 | 0.509 |
LIG_PCNA_yPIPBox_3 | 109 | 121 | PF02747 | 0.516 |
LIG_PDZ_Class_2 | 270 | 275 | PF00595 | 0.559 |
LIG_SH2_STAP1 | 221 | 225 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.432 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.456 |
LIG_SH3_3 | 95 | 101 | PF00018 | 0.569 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.563 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.511 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.479 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.566 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.474 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.508 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.569 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.677 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.323 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.176 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.514 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.620 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.675 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.681 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.581 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.725 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.430 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.464 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.445 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.498 |
MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.563 |
MOD_N-GLC_1 | 174 | 179 | PF02516 | 0.235 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.423 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.691 |
MOD_NEK2_1 | 223 | 228 | PF00069 | 0.469 |
MOD_PIKK_1 | 105 | 111 | PF00454 | 0.619 |
MOD_PK_1 | 207 | 213 | PF00069 | 0.474 |
MOD_PKA_2 | 223 | 229 | PF00069 | 0.408 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.686 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.492 |
MOD_Plk_2-3 | 159 | 165 | PF00069 | 0.566 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.490 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.684 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.356 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.483 |
MOD_SUMO_rev_2 | 264 | 274 | PF00179 | 0.576 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.448 |
TRG_ER_diArg_1 | 117 | 120 | PF00400 | 0.566 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IH00 | Leptomonas seymouri | 62% | 99% |
A0A0S4IJ87 | Bodo saltans | 37% | 100% |
A0A0S4JAL6 | Bodo saltans | 35% | 100% |
A0A1X0NZY8 | Trypanosomatidae | 32% | 100% |
A0A3Q8IIW1 | Leishmania donovani | 85% | 98% |
A0A422NNL4 | Trypanosoma rangeli | 38% | 100% |
A4I4P3 | Leishmania infantum | 85% | 98% |
C9ZLD4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 100% |
E9AE46 | Leishmania major | 81% | 99% |
E9ALN9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 98% |
V5BBV3 | Trypanosoma cruzi | 38% | 100% |